Skip to main content

Table 7 Base case results—tiotropium vs usual care

From: Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden

 

UC

TIO

TIO–UC

Costs (SEK 2014)

 Treatment costs

0

17,315

17,315

 Direct costs

167,654

165,380

−2274

 Total costs

167,654

182,695

15,041

Health outcomes

 QALYs

7.18

7.25

0.07

 Life years

10.18

10.26

0.08

ICER

224,850

  1. All costs and effects discounted at an annual rate of 3 %
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us